{
    "data": [
        {
            "id": 2983779,
            "title": "J.P. Morgan Reaffirms Their Buy Rating on Schneider Electric (0NWV)",
            "description": "<html><head></head><body><p>In a report released today, <a href=\"https://www.tipranks.com/experts/analysts/phil-buller\" target=\"_blank\" style=\"color:blue\">Phil Buller</a> from J.P. Morgan maintained a Buy rating on Schneider Electric, with a price target of <span id=\"expert-recommendation-target\">€325.00</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Buller covers the Industrials sector, focusing on stocks such as Schneider Electric, Siemens, and Siemens Energy. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Buller has an average return of <span style=\"color:green;font-weight:bold;\">19.0%</span> and a 61.95% success rate on recommended stocks. </p>\n<p>In a report released today, <a data-autolink=\"true\" href=\"https://www.tipranks.com/experts/firms/rbc-capital\">RBC Capital</a> also maintained a Buy rating on the stock with a €270.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-7-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/j-p-morgan-reaffirms-their-buy-rating-on-schneider-electric-0nwv-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 05:56:08",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983585,
            "title": "Roth MKM Sticks to Their Buy Rating for HEALWELL AI (AIDX)",
            "description": "<html><head></head><body><p>Roth MKM analyst <a href=\"https://www.tipranks.com/experts/analysts/kyle-bauser\" target=\"_blank\" style=\"color:blue\">Kyle Bauser</a> reiterated a Buy rating on HEALWELL <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> today and set a price target of C$2.50.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Bauser is an analyst with an average return of <span style=\"color:red;font-weight:bold;\">-13.0%</span> and a 35.92% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Electromed, HEALWELL AI, and Apyx Medical.</p>\n<p>In a report released on February 12, Haywood also maintained a Buy rating on the stock with a C$4.50 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1549769756-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-their-buy-rating-for-healwell-ai-aidx-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 05:25:33",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983435,
            "title": "Acumen Capital Reaffirms Their Buy Rating on Tamarack Valley Energy (TNEYF)",
            "description": "<html><head></head><body><p>In a report released today,  from Acumen Capital maintained a Buy rating on Tamarack Valley Energy, with a price target of <span id=\"expert-recommendation-target\">C$10.50</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p></p>\n<p>In addition to Acumen Capital, Tamarack Valley Energy also received a Buy from Desjardins’s Chris MacCulloch in a report issued today. However, on the same day, Canaccord Genuity maintained a Hold rating on Tamarack Valley Energy (Other OTC: TNEYF).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Energy-5-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/acumen-capital-reaffirms-their-buy-rating-on-tamarack-valley-energy-tneyf-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 04:37:06",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983436,
            "title": "Exchange Income (EIF) Receives a Buy from Raymond James",
            "description": "<html><head></head><body><p>In a report released today, <a href=\"https://www.tipranks.com/experts/analysts/steve-hansen\" target=\"_blank\" style=\"color:blue\">Steve Hansen</a> from Raymond James maintained a Buy rating on Exchange Income, with a price target of <span id=\"expert-recommendation-target\">C$125.00</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Hansen covers the Industrials sector, focusing on stocks such as Exchange Income, Ag Growth International, and Cargojet. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Hansen has an average return of <span style=\"color:green;font-weight:bold;\">5.7%</span> and a 54.91% success rate on recommended stocks. </p>\n<p>In addition to Raymond James, Exchange Income also received a Buy from ATB Cormark Capital Markets’s Jeff Fenwick in a report issued today. However, on the same day, TipRanks – xAI reiterated a Hold rating on Exchange Income (TSX: EIF).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/exchange-income-eif-receives-a-buy-from-raymond-james-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 04:37:15",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983437,
            "title": "BTB REIT (BTB.UN) was downgraded to a Hold Rating at Canaccord Genuity",
            "description": "<html><head></head><body><p>BTB REIT received a Hold rating and a C$4.25 price target from Canaccord Genuity analyst <a href=\"https://www.tipranks.com/experts/analysts/mark-rothschild\" target=\"_blank\" style=\"color:blue\">Mark Rothschild</a> today.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Rothschild is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">10.6%</span> and a 69.98% success rate. Rothschild covers the Real Estate sector, focusing on stocks such as DREAM Un Cl A, Storagevault Canada, and RioCan Real Estate Investment.</p>\n<p>BTB REIT has an analyst consensus of Hold, with a price target consensus of C$4.25.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/shutterstock_261540053-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/btb-reit-btb-un-was-downgraded-to-a-hold-rating-at-canaccord-genuity-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 04:37:24",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983424,
            "title": "5N Plus (VNP) Gets a Buy from Ventum Financial",
            "description": "<html><head></head><body><p>Ventum Financial analyst  maintained a Buy rating on 5N Plus today and set a price target of C$35.00.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p></p>\n<p>In addition to Ventum Financial, 5N Plus also received a Buy from TipRanks – OpenAI’s OpenAI Materials CA in a report issued today. However, on the same day, TipRanks – Anthropic downgraded 5N Plus (TSX: VNP) to a Hold.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2098623484-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/5n-plus-vnp-gets-a-buy-from-ventum-financial-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 04:35:56",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983375,
            "title": "Thryv: Strategic SaaS Transition Clouds Near-Term Growth Visibility, Supporting a Neutral Hold Rating",
            "description": "<html><head></head><body><p>William Blair analyst <a href=\"https://www.tipranks.com/experts/analysts/arjun-bhatia\" target=\"_blank\" style=\"color:blue\">Arjun Bhatia</a> has reiterated their neutral  stance on <span class=\"tr-stock-ticker\" style=\"color:blue; font-weight:bold\"><a href=\"https://www.tipranks.com/stocks/thry\" target=\"_blank\" ;=\"\" rel=\"nofollow\">THRY</a></span> stock, giving a Hold rating on February 20.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Arjun Bhatia has given his Hold rating due to a combination of factors tied to Thryv’s strategic transition and its impact on growth visibility. The company is shifting to its new Market, Sell, Grow platform and dialing back its older multiproduct and legacy marketing-services motions, which has already led to a sizable revenue guidance shortfall and implies that 2026 will be a reset year with meaningfully slower SaaS growth than in 2025.</p>\n<p>As Thryv reduces its dependence on migrating legacy clients and instead leans more on still-developing organic customer acquisition and expansion, execution risk increases and the near-term growth trajectory becomes harder to forecast. Although the shares trade at what appear to be inexpensive multiples on 2026 SaaS revenue and EBITDA (especially if one assumes little value for the legacy operations), Bhatia sees the stock remaining out of favor until investors gain better clarity on the company’s sustainable growth rate, supporting a neutral, or Hold, stance rather than a more decisive buy or sell call.</p>\n<p>In another report released on February 20, <a data-autolink=\"true\" href=\"https://www.tipranks.com/experts/firms/rbc-capital\">RBC Capital</a> also maintained a Hold rating on the stock with a $7.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Communication-Services-3-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/thryv-strategic-saas-transition-clouds-near-term-growth-visibility-supporting-a-neutral-hold-rating-ratings-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 03:55:21",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983329,
            "title": "Jefferies Reaffirms Their Buy Rating on D-Wave Quantum (QBTS)",
            "description": "<html><head></head><body><p>In a report released today, <a href=\"https://www.tipranks.com/experts/analysts/kevin-garrigan\" target=\"_blank\" style=\"color:blue\">Kevin Garrigan</a> from Jefferies reiterated a Buy rating on D-Wave Quantum, with a price target of <span id=\"expert-recommendation-target\">$45.00</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Garrigan is a 3-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">6.8%</span> and a 45.95% success rate. Garrigan covers the Technology sector, focusing on stocks such as IonQ, D-Wave Quantum, and Rigetti Computing.</p>\n<p>In a report released today, Needham also maintained a Buy rating on the stock with a $40.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1122339353-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-d-wave-quantum-qbts-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 03:35:18",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983311,
            "title": "Buy Rating on NCR Voyix: Strong Q4 Execution and Enterprise Wins Offset Near-Term Headwinds, Underscoring Compelling Valuation",
            "description": "<html><head></head><body><p>Needham analyst <a href=\"https://www.tipranks.com/experts/analysts/mayank-tandon\" target=\"_blank\" style=\"color:blue\">Mayank Tandon</a> maintained a Buy rating on NCR Voyix today and set a price target of $12.00.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Mayank Tandon has given his Buy rating due to a combination of factors, including NCR Voyix’s stronger‑than‑expected fourth‑quarter performance and continued momentum in landing large enterprise customers. The company’s recent wins with major brands such as Chipotle for its Aloha platform and 7‑Eleven Philippines on the retail side highlight growing adoption of its upgraded solutions and support confidence in its long‑term growth prospects.</p>\n<p>At the same time, Tandon views the softer initial FY26 EBITDA and EPS outlook as largely tied to temporary headwinds from the ODM hardware shift and restructuring expenses rather than a deterioration in the core business. Given that the shares trade at a relatively low multiple of roughly 4.5x EV/EBITDA on his FY27 forecast, he sees the current valuation as compelling versus the company’s earnings potential, justifying a Buy rating even as he trims the price target to $12.</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2170811717-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/buy-rating-on-ncr-voyix-strong-q4-execution-and-enterprise-wins-offset-near-term-headwinds-underscoring-compelling-valuation-ratings-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 03:25:23",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983253,
            "title": "Gold79 Mines (WPG) Initiated with a Buy at ATB Cormark Capital Markets",
            "description": "<html><head></head><body><p>Gold79 Mines received a Buy rating and a C$2.75 price target from ATB Cormark Capital Markets analyst  today.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p></p>\n<p>Currently, the analyst consensus on Gold79 Mines is a Moderate Buy with an average price target of C$2.75.</p>",
            "image": "",
            "link": "https://www.tipranks.com/news/blurbs/gold79-mines-wpg-initiated-with-a-buy-at-atb-cormark-capital-markets-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 02:45:29",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983279,
            "title": "TWFG, Inc. Class A: Accelerating Organic Growth, Margin Upside, and Cash-Flow-Fueled Capital Returns Support Buy Rating",
            "description": "<html><head></head><body><p>William Blair analyst <a href=\"https://www.tipranks.com/experts/analysts/adam-klauber\" target=\"_blank\" style=\"color:blue\">Adam Klauber</a> has maintained their bullish  stance on <span class=\"tr-stock-ticker\" style=\"color:blue; font-weight:bold\"><a href=\"https://www.tipranks.com/stocks/twfg\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TWFG</a></span> stock, giving a Buy rating on February 23.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Adam Klauber has given his Buy rating due to a combination of factors, including TWFG, Inc. Class A’s stronger-than-expected revenue and adjusted EBITDA, which were driven by better contingent commissions, M&amp;A contributions, and lower commission costs from a recent Florida program acquisition. He also notes that organic growth remains solid at around the low-teens, with new business expanding at its fastest rate in several years and retention holding in the low-90% range, despite some rate softening, particularly in auto.</p>\n<p>Looking ahead, Klauber points to management’s guidance for double-digit organic expansion and high-teens total revenue growth, with EBITDA expectations modestly above market forecasts thanks to favorable mix toward higher-margin branches and MGA operations. He highlights the company’s robust free cash flow and healthy balance sheet as key enablers of ongoing acquisitions and planned share repurchases, and he believes the current valuation around 13x 2027 EV/EBITDA is attractive given the accelerating growth profile and potential for 15% to 20% long-term compounding in earnings and cash flow.</p>\n<p>Klauber covers the Financial sector, focusing on stocks such as Progressive, Allstate, and Ehealth. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Klauber has an average return of <span style=\"color:red;font-weight:bold;\">-4.7%</span> and a 35.68% success rate on recommended stocks. </p>\n<p>In another report released on February 23, Piper Sandler also maintained a Buy rating on the stock with a $22.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2092362163-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/twfg-inc-class-a-accelerating-organic-growth-margin-upside-and-cash-flow-fueled-capital-returns-support-buy-rating-ratings-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 03:05:22",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983266,
            "title": "Bentley Systems: Durable Double-Digit Growth and Underappreciated Cash Flow Support Buy Rating",
            "description": "<html><head></head><body><p>William Blair analyst <a href=\"https://www.tipranks.com/experts/analysts/dylan-becker\" target=\"_blank\" style=\"color:blue\">Dylan Becker</a> has reiterated their bullish  stance on <span class=\"tr-stock-ticker\" style=\"color:blue; font-weight:bold\"><a href=\"https://www.tipranks.com/stocks/bsy\" target=\"_blank\" ;=\"\" rel=\"nofollow\">BSY</a></span> stock, giving a Buy rating on February 24.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Dylan Becker has given his Buy rating due to a combination of factors tied to Bentley Systems’ recent performance and outlook. The company delivered robust fourth‑quarter results, with subscription revenue and ARR growing at low‑teens rates on a constant‑currency basis, underpinned by record infrastructure backlogs and rising adoption of its software to address capacity constraints.</p>\n<p>Looking ahead, management’s initial 2026 guidance calls for similar low‑teens growth across total revenue, subscriptions, and ARR, alongside further operating margin expansion, reinforcing a durable Rule‑of‑40‑plus profile. Despite broader concerns about <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a>‑driven disruption in software, Becker views Bentley’s differentiated design platform, healthy infrastructure demand, and projected mid‑teens cash flow growth as not fully reflected in the current valuation at roughly 21x his 2026 cash flow estimate, justifying a Buy recommendation.</p>\n<p>In another report released on February 24, Rosenblatt Securities also maintained a Buy rating on the stock with a $50.00 price target.</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_264965759-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/bentley-systems-durable-double-digit-growth-and-underappreciated-cash-flow-support-buy-rating-ratings-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 02:55:45",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2983189,
            "title": "Rhythm Pharmaceuticals: Imcivree Momentum and Bivamelanotide Pipeline Catalysts Underpin Buy Rating and $130 Target",
            "description": "<html><head></head><body><p>TD Cowen analyst <a href=\"https://www.tipranks.com/experts/analysts/phil-nadeau\" target=\"_blank\" style=\"color:blue\">Phil Nadeau</a> maintained a Buy rating on Rhythm Pharmaceuticals today and set a price target of $130.00.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Phil Nadeau has given his Buy rating due to a combination of factors, including solid commercial performance of Imcivree and clear upcoming growth catalysts. Imcivree’s fourth-quarter revenue rose both sequentially and year over year, supported by an expanding treated patient base, and the firm expects hypothalamic obesity, once approved, to become a key growth engine through 2026.</p>\n<p>Phil Nadeau’s rating is based on the view that the pipeline further strengthens Rhythm’s outlook, particularly the oral candidate bivamelanotide, which has shown encouraging and durable BMI reductions in Phase II extension data. With pivotal trials for biva planned, two important Imcivree datasets due in March, and a near-term PDUFA decision that should broaden the label, he believes the company’s fundamentals support a $130 price target and justify a Buy recommendation.</p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Nadeau is a 4-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">7.5%</span> and a 48.13% success rate. Nadeau covers the Healthcare sector, focusing on stocks such as Rhythm Pharmaceuticals, Vir Biotechnology, and BioMarin Pharmaceutical.</p>\n<p>In another report released on February 18, <a data-autolink=\"true\" href=\"https://www.tipranks.com/experts/firms/rbc-capital\">RBC Capital</a> also initiated coverage with a Buy rating on the stock with a $145.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1561815367-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/rhythm-pharmaceuticals-imcivree-momentum-and-bivamelanotide-pipeline-catalysts-underpin-buy-rating-and-130-target-ratings-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 02:15:24",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982689,
            "title": "CGS International Reaffirms Their Buy Rating on China Yuchai International (CYD)",
            "description": "<html><head></head><body><p>In a report released yesterday,  from CGS International maintained a Buy rating on China Yuchai International, with a price target of <span id=\"expert-recommendation-target\">$65.00</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p></p>\n<p>Currently, the analyst consensus on China Yuchai International is a Moderate Buy with an average price target of $62.50.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Cylical-3-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/cgs-international-reaffirms-their-buy-rating-on-china-yuchai-international-cyd-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 01:15:55",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982690,
            "title": "Roth MKM Sticks to Its Buy Rating for Redwire (RDW)",
            "description": "<html><head></head><body><p>In a report released today, <a href=\"https://www.tipranks.com/experts/analysts/sujeeva-de-silva\" target=\"_blank\" style=\"color:blue\">Sujeeva De Silva</a> from Roth MKM maintained a Buy rating on Redwire, with a price target of <span id=\"expert-recommendation-target\">$20.00</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, De Silva is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">32.4%</span> and a 47.57% success rate. De Silva covers the Technology sector, focusing on stocks such as Marvell, Advanced Micro Devices, and Netlist.</p>\n<p>In addition to Roth MKM, Redwire also received a Buy from Cantor Fitzgerald’s Colin Canfield in a report issued yesterday. However, today, TipRanks – OpenAI reiterated a Hold rating on Redwire (NYSE: RDW).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-its-buy-rating-for-redwire-rdw-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 01:16:04",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982610,
            "title": "ABB India Limited (ABB) Receives a Hold from ICICI Securities",
            "description": "<html><head></head><body><p>ICICI Securities analyst  maintained a Hold rating on ABB India Limited today and set a price target of INR6,800.00.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p></p>\n<p>In addition to ICICI Securities, ABB India Limited also received a Hold from TipRanks – Anthropic’s Anthropic Industrials IN in a report issued on February 20. However, on the same day, TipRanks – OpenAI upgraded ABB India Limited (NSE: ABB) to a Buy.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/abb-india-limited-abb-receives-a-hold-from-icici-securities-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-27 00:55:53",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982295,
            "title": "Jefferies Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)",
            "description": "<html><head></head><body><p>Jefferies analyst <a href=\"https://www.tipranks.com/experts/analysts/akash-tewari\" target=\"_blank\" style=\"color:blue\">Akash Tewari</a> maintained a Buy rating on Ionis Pharmaceuticals today and set a price target of $96.00.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Tewari is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">13.6%</span> and a 56.76% success rate. Tewari covers the Healthcare sector, focusing on stocks such as Argenx Se, Neurocrine, and BioMarin Pharmaceutical.</p>\n<p>In addition to Jefferies, Ionis Pharmaceuticals also received a Buy from Morgan Stanley’s Michael Ulz in a report issued today. However, on the same day, <a data-autolink=\"true\" href=\"https://www.tipranks.com/experts/firms/stifel-nicolaus\">Stifel Nicolaus</a> maintained a Hold rating on Ionis Pharmaceuticals (NASDAQ: IONS).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2127549605-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-ionis-pharmaceuticals-ions-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-26 23:45:48",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982249,
            "title": "Jefferies Sticks to Their Buy Rating for GlaxoSmithKline (GSK)",
            "description": "<html><head></head><body><p>Jefferies analyst <a href=\"https://www.tipranks.com/experts/analysts/michael-leuchten\" target=\"_blank\" style=\"color:blue\">Michael Leuchten</a> maintained a Buy rating on GlaxoSmithKline today and set a price target of £24.50.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Leuchten is an analyst with an average return of <span style=\"color:red;font-weight:bold;\">-4.5%</span> and a 50.67% success rate. Leuchten covers the Healthcare sector, focusing on stocks such as Novo Nordisk, GlaxoSmithKline, and Roche Holding AG.</p>\n<p>Currently, the analyst consensus on GlaxoSmithKline is a Hold with an average price target of p1,952.86.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1561815367-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-glaxosmithkline-gsk-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-26 23:35:35",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982057,
            "title": "Honest Company (HNST) Gets a Hold from Telsey Advisory",
            "description": "<html><head></head><body><p>In a report released today, <a href=\"https://www.tipranks.com/experts/analysts/joe-feldman\" target=\"_blank\" style=\"color:blue\">Joe Feldman</a> from Telsey Advisory maintained a Hold rating on Honest Company, with a price target of <span id=\"expert-recommendation-target\">$3.00</span>.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Feldman is a 4-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">6.1%</span> and a 52.56% success rate. Feldman covers the Consumer Cyclical sector, focusing on stocks such as Floor &amp; Decor Holdings, Five Below, and Home Depot.</p>\n<p>In addition to Telsey Advisory, Honest Company also received a Hold from TipRanks – PerPlexity’s PerPlexity Specialty Retail in a report issued today. However, on the same day, Northland Securities maintained a Buy rating on Honest Company (NASDAQ: HNST).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Defensive-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/honest-company-hnst-gets-a-hold-from-telsey-advisory-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-26 22:56:37",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2982059,
            "title": "Oppenheimer Remains a Buy on Satellos Bioscience (MSLE)",
            "description": "<html><head></head><body><p>Oppenheimer analyst <a href=\"https://www.tipranks.com/experts/analysts/kostas-biliouris\" target=\"_blank\" style=\"color:blue\">Kostas Biliouris</a> maintained a Buy rating on Satellos Bioscience yesterday and set a price target of $40.00. The company’s shares opened today at C$15.74.</p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Biliouris is an analyst with an average return of <span style=\"color:red;font-weight:bold;\">-1.1%</span> and a 40.65% success rate. Biliouris covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Sarepta Therapeutics, and Centessa Pharmaceuticals.</p>\n<p>Satellos Bioscience has an analyst consensus of Moderate Buy, with a price target consensus of $28.00, implying a 77.89% upside from current levels. In a report released on February 11, Leede Financial also reiterated a Buy rating on the stock with a $16.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1931544818-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-satellos-bioscience-msle-blurbs-news",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2026-02-26 22:56:47",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        }
    ]
}